NCT03274141View on ClinicalTrials.gov

Comparing the Effectiveness of a Treat-to-target (T2T) Disease Management Strategy vs. Routine Care (RC) in Adult Patients With Moderate to Severe Rheumatoid Arthritis (RA) Treated With Subcutaneous Abatacept (Orencia - SC)

CompletedOBSERVATIONAL
Enrollment

281

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions
Rheumatoid Arthritis
Interventions
OTHER

Non-Interventional

Non-Interventional

Trial Locations (1)

H3Z 1R7

Local Institution, Westmount

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT03274141 - Comparing the Effectiveness of a Treat-to-target (T2T) Disease Management Strategy vs. Routine Care (RC) in Adult Patients With Moderate to Severe Rheumatoid Arthritis (RA) Treated With Subcutaneous Abatacept (Orencia - SC) | Biotech Hunter | Biotech Hunter